18 results match your criteria: "Mohak Bariatrics and Robotics Center[Affiliation]"
VideoGIE
October 2024
Mohak Bariatrics and Robotics Center, Sri Aurobindo University, Indore, India.
Objective: This study aimed to evaluate the technical variations of one-anastomosis gastric bypass (OAGB) among IFSO-APC and MENAC experts.
Background: The multitude of technical variations and patient selection challenges among metabolic and bariatric surgeons worldwide necessitates a heightened awareness of these issues. Understanding different perspectives and viewpoints can empower surgeons performing OAGB to adapt their techniques, leading to improved outcomes and reduced complications.
Obes Surg
January 2024
Mohak Bariatrics and Robotics Center, Sri Aurobindo University, Indore-Ujjain Highway, Indore, Madhya Pradesh, 453555, India.
Background: Obesity is a significant public health issue; new therapies and pharmaceutical approaches to weight management are needed.
Objective: This study assesses weight reduction efficacy in the novel swallow balloon procedure and semaglutide, both promising non-surgical and pharmaceutical options, addressing obesity's critical public health challenge.
Methods: This was a computer-generated, blocked randomisation, double-blind, single-centre study.
Surg Endosc
March 2023
Department of Surgery, State University of New York, Buffalo, NY, USA.
Obes Surg
October 2022
Sri Aurobindo Medical College and PG Institute, Sri Aurobindo University, Indore, Madhya Pradesh, India.
Purpose: Bariatric surgery has been proven to be a successful management strategy for morbid obesity, but limited studies exist on its effect on polycystic ovary syndrome (PCOS) in terms of clinical, hormonal, and comorbidities.
Materials And Methods: This is a prospective observational study of 1013 PCOS patients who underwent bariatric surgery from a single high-volume center. Assessment of demographic data and menstrual irregularity as well as hirsutism and comorbidities was done preoperatively 6-month and yearly follow-up, whereas data regarding %TWL and %EWL was taken at follow-up visits conducted at regular intervals of 6 months, and 1, 2, 3, 4, and 5 years following surgery.
Obes Surg
August 2022
Department of General Surgery, Rovigo Hospital, Rovigo, Italy.
Purpose: One anastomosis/mini gastric bypass (OAGB/MGB) is up to date the third most performed obesity and metabolic procedure worldwide, which recently has been endorsed by ASMBS. The main criticisms are the risk of bile reflux, esophageal cancer, and malnutrition. Although IFSO has recognized this procedure, guidance is needed regarding selection criteria.
View Article and Find Full Text PDFJ Minim Access Surg
January 2022
Mohak Bariatrics and Robotics Center, SAIMS Campus, Indore, Madhya Pradesh, India.
Background: Bariatric metabolic surgery is evolving as an option for the treatment of type 2 diabetes mellitus (T2DM) in patients with obesity and T2DM, warranting more studies on the efficacy of bariatric metabolic surgery on T2DM.
Objective: To determine T2DM remission in patients with obesity and T2DM with up to two years follow-up after bariatric metabolic surgery.
Materials And Methods: A retrospective review of prospectively maintained data was undertaken to identify patients who had T2DM and underwent bariatric surgery at a single centre in 2016.
Surg Clin North Am
April 2021
Mohak Bariatrics and Robotics Center, SAIMS Campus, Indore-Ujjain Highway, Indore, Madhya Pradesh, India.
Bariatric/metabolic surgery has emerged as an option for significant and durable weight loss in the treatment of clinically severe obesity; there is increasing demand for bariatric/metabolic surgery worldwide. New procedures have been developed and changed the face of modern bariatric surgery. Gastrointestinal metabolic surgery is a new treatment modality for obesity-related type 2 diabetes mellitus for patients with body mass index greater than 35 kg/m.
View Article and Find Full Text PDFUpdates Surg
September 2020
Institute of Minimal Access, Metabolic and Bariatric Surgery, Max Superspecialty Hospital, Saket, New Delhi, India.
Bariatric and metabolic surgery are being performed in India for 2 decades. Aim of this paper is to evaluate the changing clinical trends over the last 5 years and to present the other aspects helmed by Obesity and Metabolic Surgery Society of India (OSSI) to aid the growth of research, education, data management and registry, quality control, insurance-related issues and policy change. OSSI conducts an annual survey to collect data pertaining to numbers of surgical procedures.
View Article and Find Full Text PDFSurg Obes Relat Dis
June 2020
Mohak Bariatrics and Robotics Center, SAIMS Campus, Madhya Pradesh, India.
Obes Surg
June 2020
Institute of Minimal Access, Metabolic and Bariatric Surgery, Max Super Speciality Hospital, Saket, New Delhi, India.
Background: India is the largest hub for bariatric and metabolic surgery in Asia. OSSI is committed to improve the quality of care and set the standards for its practice in India.
Methods: The first draft of OSSI guidelines was prepared by the secretary, Dr.
Obesity (Silver Spring)
February 2020
Mohak Bariatrics and Robotics Center, Indore, India.
Obes Surg
April 2020
Mohak Bariatrics and Robotics Center, SAIMS Campus, Indore-Ujjain Highway, Indore, Madhya Pradesh, India.
Surg Obes Relat Dis
December 2019
Mohak Bariatrics and Robotics Center, SAIMS Campus, Indore-Ujjain Indore, Madhya Pradesh, India.
Background: Roux-en-Y gastric bypass (RYGB) is the gold standard in bariatric surgery. One-anastomosis gastric bypass (OAGB) has been reported to have equivalent or better weight loss, with added advantages of being technically easy, amenable to reintervention/reversal, and offering better food tolerance.
Objective: This study was undertaken to compare weight loss, metabolic syndrome outcome, complications, and long-term nutritional outcomes between the 2 procedures.
Surg Obes Relat Dis
December 2019
Mohak Bariatrics and Robotics Center, SAIMS Campus, Madhya Pradesh, India.
Background: There are few publications on revising sleeve gastrectomy (SG) to one-anastomosis gastric bypass (OAGB).
Objective: This study was undertaken to determine outcomes in terms of weight loss and resolution of co-morbidities in patients who had SG revised to OAGB.
Settings: A high-volume university-affiliated bariatric surgery center in India.
Surg Obes Relat Dis
December 2019
Mohak Bariatrics and Robotics Center, Indore, Madhya Pradesh, India.
Introduction: Functional ability is often impaired as a direct consequence of severe obesity. Bariatric surgery is the most effective treatment for severe obesity.
Objective: To examine the effect of weight loss after bariatric surgery on patients with impaired functional ambulatory abilities due to obesity.
Dig Endosc
May 2020
Department of Bariatric and Metabolic Surgery, Mohak Bariatrics and Robotics Center, Indore, India.
Background And Aim: Endoscopic sleeve gastroplasty (ESG) is gaining acceptance as a non-surgical option for the treatment of obesity. However, its role is still not consolidated for all populations and the ideal indications are yet to be determined. We aimed to study the efficacy and safety of ESG in Indian patients.
View Article and Find Full Text PDFTwo modifications of Roux-en-Y gastric bypass (RYGB), one anastomosis gastric bypass (OAGB) and Roux-en-Y banded gastric bypass (BGBP), are gaining popularity in use because the OAGB is reported to be a simpler operation, and the BGBP is reported to have sustained weight loss compared to standard RYGB. A retrospective review and analysis of data comparing outcomes up to 5 years after BGBP and OAGB from a prospectively maintained database of all bariatric metabolic operations in 2012 was performed. Eighty-two patients underwent a BGBP and 90 an OAGB.
View Article and Find Full Text PDF